Drugs / PPP011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04001010 | Jul 2022 → Jul 2023 | cannabis dependence, hypoproteinemia, hypercatabolic | Tetra Bio-Pharma | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PPP011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04001010 ↗ |
| Route | Inhaled | “1 capsule inhaled 3 times a day with a vaporizer device” NCT04001010 ↗ |